274 related articles for article (PubMed ID: 19727766)
1. ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective.
Pozzobon M; Ghionzoli M; De Coppi P
Pediatr Surg Int; 2010 Jan; 26(1):3-10. PubMed ID: 19727766
[TBL] [Abstract][Full Text] [Related]
2. Stem cells from amniotic fluid--Potential for regenerative medicine.
Loukogeorgakis SP; De Coppi P
Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():45-57. PubMed ID: 26542929
[TBL] [Abstract][Full Text] [Related]
3. Amniotic fluid-derived stem cells in regenerative medicine research.
Joo S; Ko IK; Atala A; Yoo JJ; Lee SJ
Arch Pharm Res; 2012 Feb; 35(2):271-80. PubMed ID: 22370781
[TBL] [Abstract][Full Text] [Related]
4. Congenital anomalies: treatment options based on amniotic fluid-derived stem cells.
Kunisaki SM
Organogenesis; 2012; 8(3):89-95. PubMed ID: 22986340
[TBL] [Abstract][Full Text] [Related]
5. Reprogrammed cells for disease modeling and regenerative medicine.
Cherry AB; Daley GQ
Annu Rev Med; 2013; 64():277-90. PubMed ID: 23327523
[TBL] [Abstract][Full Text] [Related]
6. [Utilization of the ES/iPS cell technology for hematopoietic stem cell transplantation].
Otsu M; Nakauchi H
Nihon Rinsho; 2012 Apr; 70 Suppl 2():146-50. PubMed ID: 23133943
[No Abstract] [Full Text] [Related]
7. The decision on the "optimal" human pluripotent stem cell.
Rosner M; Schipany K; Hengstschläger M
Stem Cells Transl Med; 2014 May; 3(5):553-9. PubMed ID: 24692589
[TBL] [Abstract][Full Text] [Related]
8. Stem cell therapy as an option for pediatric surgical conditions.
Zani A; De Coppi P
Eur J Pediatr Surg; 2014 Jun; 24(3):219-26. PubMed ID: 24945441
[TBL] [Abstract][Full Text] [Related]
9. Cell therapy using induced pluripotent stem cells or somatic stem cells: this is the question.
Somoza RA; Rubio FJ
Curr Stem Cell Res Ther; 2012 May; 7(3):191-6. PubMed ID: 22329581
[TBL] [Abstract][Full Text] [Related]
10. Human Amniotic Fluid Stem Cells: Therapeutic Potential for Perinatal Patients with Intractable Neurological Disease.
Ochiai D; Masuda H; Abe Y; Otani T; Fukutake M; Matsumoto T; Miyakoshi K; Tanaka M
Keio J Med; 2018 Dec; 67(4):57-66. PubMed ID: 29515049
[TBL] [Abstract][Full Text] [Related]
11. [Regenerative therapy for post-stroke patients].
Yamashita T; Abe K
Nihon Rinsho; 2016 Apr; 74(4):661-5. PubMed ID: 27333756
[TBL] [Abstract][Full Text] [Related]
12. The Potential of Different Origin Stem Cells in Modulating Oral Bone Regeneration Processes.
Buduru SD; Gulei D; Zimta AA; Tigu AB; Cenariu D; Berindan-Neagoe I
Cells; 2019 Jan; 8(1):. PubMed ID: 30625993
[TBL] [Abstract][Full Text] [Related]
13. Human embryonic stem cells vs human induced pluripotent stem cells for cardiac repair.
Barad L; Schick R; Zeevi-Levin N; Itskovitz-Eldor J; Binah O
Can J Cardiol; 2014 Nov; 30(11):1279-87. PubMed ID: 25442431
[TBL] [Abstract][Full Text] [Related]
14. The potential of amniotic fluid stem cells for cellular therapy and tissue engineering.
Klemmt PA; Vafaizadeh V; Groner B
Expert Opin Biol Ther; 2011 Oct; 11(10):1297-314. PubMed ID: 21623704
[TBL] [Abstract][Full Text] [Related]
15. [Which stem cells to repair the endocrine pancreas?].
Duvillié B
Med Sci (Paris); 2013; 29(8-9):744-8. PubMed ID: 24005629
[TBL] [Abstract][Full Text] [Related]
16. ES and iPS cell research for cardiovascular regeneration.
Yamashita JK
Exp Cell Res; 2010 Oct; 316(16):2555-9. PubMed ID: 20385126
[TBL] [Abstract][Full Text] [Related]
17. Pluripotent stem cell replacement approaches to treat type 1 diabetes.
Pellegrini S; Piemonti L; Sordi V
Curr Opin Pharmacol; 2018 Dec; 43():20-26. PubMed ID: 30071348
[TBL] [Abstract][Full Text] [Related]
18. Regenerative cells for transplantation in hepatic failure.
Ishikawa T; Banas A; Teratani T; Iwaguro H; Ochiya T
Cell Transplant; 2012; 21(2-3):387-99. PubMed ID: 22793046
[TBL] [Abstract][Full Text] [Related]
19. [Retinal cell therapy using iPS cells].
Takahashi M
Rinsho Shinkeigaku; 2013; 53(11):1016. PubMed ID: 24291864
[No Abstract] [Full Text] [Related]
20. Stem cell-based treatments for Type 1 diabetes mellitus: bone marrow, embryonic, hepatic, pancreatic and induced pluripotent stem cells.
Godfrey KJ; Mathew B; Bulman JC; Shah O; Clement S; Gallicano GI
Diabet Med; 2012 Jan; 29(1):14-23. PubMed ID: 21883442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
